What this Trial Is About

Researchers are evaluating the use of vibrators to improve sexual and pelvic floor function in women with urogynecologic conditions who experience sexual dysfunction. This study addresses the limited existing data and the lack of randomized controlled trials on vibrators as a therapeutic tool in this population. Participants include women diagnosed with conditions such as pelvic organ prolapse, urgency incontinence, overactive bladder, stress urinary incontinence, or fecal incontinence, including those recovering from urogynecologic surgery and cleared for intercourse. Participants will receive either an FDA-approved vibrator device or an instructional handout on improving sexual dysfunction. The intervention involves vibrator use intended to enhance sexual and pelvic floor function. Women must be willing to use the vibrator and must not have used one in the past three months. The study includes screening with the Female Sexual Function Index (FSFI) to identify eligible participants with scores below 26.55. During the study, participants will be monitored for changes in sexual function using the FSFI up to 12 weeks. Researchers will assess sexual and pelvic floor function to evaluate the vibrator's role as a therapeutic tool. Participants must provide informed consent and be able to read and write in English. Safety is monitored, especially for those recovering from surgery, with specific timing restrictions related to recent surgeries and clearance for intercourse.

Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients